|
Post by brotherm1 on Aug 30, 2018 20:10:19 GMT -5
But they met with the FDA who liked Trep and I’am sure they have good reasons we might not even be aware of for not going with Epi. .I just find it hard to believe some don’t think inhaled epinephrine could capture a huge part of that big maket. Anyone remeber off the top of their head what the gross world sales are for epinephrine? I don’t for sure but I thought it was around $30 billion a year or so ago?
Of course with competion such as a generic pen - that was said above was approved by the FDA recently, if true - I suppose that $ figure could be quickly cut very significantly.
Sorry if I got of topic, when I think in billions of dollars I often lose touch with reality.
|
|
|
Post by anderson on Sept 1, 2018 7:36:20 GMT -5
But they met with the FDA who liked Trep and I’am sure they have good reasons we might not even be aware of for not going with Epi. .I just find it hard to believe some don’t think inhaled epinephrine could capture a huge part of that big maket. Anyone remeber off the top of their head what the gross world sales are for epinephrine? I don’t for sure but I thought it was around $30 billion a year or so ago? Of course with competion such as a generic pen - that was said above was approved by the FDA recently, if true - I suppose that $ figure could be quickly cut very significantly. Sorry if I got of topic, when I think in billions of dollars I often lose touch with reality. Epi hype also might have been a way to get some leverage over Amphastar to get a better deal since it would compete with their primatene mist(if they ever get FDA approval).
|
|
|
Post by mnholdem on Sept 1, 2018 16:17:17 GMT -5
Primatine Mist was indicated for asthma before the FDA banned all aerosols using the old propellant. TreT is for indicated for PAH not for asthma. I don’t see to two in conflict with each other or how TreT poses a threat.
|
|